PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 44 |
| PubMedID- 20334678 | However, in a german study, an association between the c161→t polymorphism and the occurrence of coronary heart disease in patients with diabetes mellitus was lacking [22]. |
| PubMedID- 23036114 | Randomization will be conducted using a web-based system to ensure allocation concealment and will incorporate minimization to ensure matching for age, sex, body mass index (height and weight), diabetes mellitus, prior history of coronary heart disease, atrial fibrillation and baseline diagnosis of angina due to coronary heart disease. |
| PubMedID- 20922871 | [hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus]. |
| PubMedID- 20728955 | Association between the rs4880 superoxide dismutase 2 (c>t) gene variant and coronary heart disease in diabetes mellitus. |
| PubMedID- 25539716 | Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26385228 | Methods: this randomized, double-blind, placebo-controlled trial was performed among 60 overweight or obese and type 2 diabetes mellitus patients with coronary heart disease aged 40-85 years old. |
| PubMedID- 22629043 | A 58 year old male, a known case of ischaemic heart disease with type 2 diabetes mellitus and hypertension, who had been admitted for cerebellar stroke 2 months back, came with complaints of dry cough- (more at night), gradually increasing breathlessness (new york heart association, nyha grade-i to start with and displaying gradual progression to nyha grade iv in a period of 3 days), and swelling all over the body with minimal abdominal distension. |
| PubMedID- 22910888 | Also, high plasma adiponectin levels are associated with a lower risk of myocardial infarction in men [107], a reduced coronary heart disease risk in patients with diabetes mellitus [108], and a lower risk of acute coronary syndrome [109] (figure 1). |
| PubMedID- 24324035 | Among all participants with hypertension, black race, male sex, living in the stroke belt or buckle, higher body mass index, lower heart rate, reduced estimated glomerular filtration rate, albuminuria, diabetes mellitus, and history of stroke and coronary heart disease were associated with refractory hypertension. |
| PubMedID- 23644116 | Methods: this study was conducted among 167 patients with coronary heart disease complicated by diabetes mellitus. |
| PubMedID- 24680263 | [predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation]. |
| PubMedID- 23483825 | In patients with acute stroke, there was no significant association between serum uric acid level and diabetes mellitus, hypertension, history of ischemic heart disease, smoking, prescription rtpa, and type of stroke. |
| PubMedID- 20040882 | Purpose: the cardiovascular disease risk profile and exercise capacity of coronary heart disease patients with type 2 diabetes mellitus (dm) were measured and compared with those of nondiabetic (ndm) patients before and after a 6-week multidisciplinary cardiac rehabilitation program. |
| PubMedID- 24470342 | The objective of this study was to evaluate the effects of trimetazidine on recurrent angina pectoris and lv structure after drug-eluting stent (des) implantation in elderly multivessel coronary heart disease (chd) patients with diabetes mellitus (dm) and a left ventricular ejection fraction (lvef) of >/= 50 %. |
| PubMedID- 24843679 | We noticed an association of diabetes mellitus with different heart diseases. |
| PubMedID- 23360660 | Purpose: diabetes mellitus with coronary heart disease (dm with chd) poses a health challenge to people in china and elsewhere in the world. |
| PubMedID- 23676456 | The diseases comprised coronary heart disease (chd), chd associated with diabetes mellitus (dm), valvular heart disease and congenital heart disease. |
| PubMedID- 23496967 | Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: lp(a) phenotype, lymphocyte, and coronary heart disease. |
| PubMedID- 23573090 | Type 1 diabetes mellitus, hypertension, history of ischemic heart disease, renal impairment (serum creatinine > 150 umol/l), and valvular heart diseases were excluded. |
| PubMedID- 26190179 | Plasma brain natriuretic peptide, endothelin-1, and matrix metalloproteinase 9 expression and significance in type 2 diabetes mellitus patients with ischemic heart disease. |
| PubMedID- 25485902 | diabetes mellitus increases morbidity/mortality of ischemic heart disease. |
| PubMedID- 20523342 | Patients with type 1 diabetes mellitus, a history of ketoacidosis, ischemic heart disease, congestive heart failure or trauma, kidney or liver diseases, patients receiving insulin treatment and pregnant or lactating women were excluded from this study. |
| PubMedID- 23155698 | Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus. |
| PubMedID- 25160842 | Comparative trends in the incidence of hospitalized myocardial infarction and coronary heart disease in adults with and without diabetes mellitus in western australia from 1998 to 2010. |
| PubMedID- 23949503 | Other cardiovascular risk factors found were hypertension (93.2%), male older than 55 years (35.8%), women older than 65 years (28.1%), diabetes mellitus (28.5%), family history of coronary heart disease (17.2%), personal history of heart disease or stroke (16.7%) and smoking (6.4%). |
| PubMedID- 25454625 | Objective: to analyze the level of creatine kinase isoenzyme (ckmb), myoglobin, to explore the influence of different glucose-lowering rate on cardiac enzyme in type 2 diabetes mellitus patients with coronary heart disease (t2dmc), to search for the rational glucose-lowering rate. |
| PubMedID- 22693502 | Type 1 diabetes mellitus, hypertension, history of ischemic heart disease, renal impairment (serum creatinine >150 umol/l), and valvular heart diseases were excluded. |
| PubMedID- 21203594 | Background: recent findings indicate that symptomatic heart disease in patients with diabetes mellitus predicts poor prognosis, but cardiac involvement may occur before clinical manifestation. |
| PubMedID- 24083205 | Hence, an open label, prospective, randomized, parallel study was undertaken to investigate the hypothesis that combination therapy with atorvastatin and fenofibrate will be more effective than monotherapy with a statin/fibrate to prevent coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23302697 | Having a history of coronary heart disease with diabetes mellitus exhibited a 2.29-fold increased risk for stroke or tia during the 4.8- to 8.1-year follow-up period than patients without diabetes. |
| PubMedID- 24809916 | Thyroid stimulating hormone levels and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20140785 | Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. |
| PubMedID- 22442750 | Aim: to analyze the risk of coronary heart disease in patients with type 2 diabetes mellitus (t2dm) receiving standard medical treatment. |
| PubMedID- 22384526 | Moreover, epidemiological studies suggest that the risk of developing coronary heart disease for patient with diabetes mellitus is 2–4 times higher than their counterparts without diabetes (1). |
| PubMedID- 24002369 | Adjusted for age, sex, systolic blood pressure, heart rate, electrocardiographic left ventricular hypertrophy, clinically significant murmur, body mass index, diabetes mellitus, and history of coronary heart disease. |
| PubMedID- 23815539 | Hypertension is a major risk factor in addition to atherosclerosis and type 2 diabetes mellitus for the development of coronary heart disease and strokes. |
| PubMedID- 21499988 | It is estimated that in the next 10 years, the majority of all heart disease will be associated with type 2 diabetes mellitus [63]. |
| PubMedID- 23413692 | [increased myelopepoxidase activity is a risk factor for ishemic heart disease in patients with diabetes mellitus]. |
| PubMedID- 23220502 | Methods: a total of 132 type 2 diabetes mellitus without coronary heart disease (t2dm) cases and 135 type 2 diabetes mellitus with coronary heart disease (t2dm+chd) cases received intensive glycemic control. |
| PubMedID- 25823606 | It was also raised in high-risk pregnancies (33.7u/ml), specifically pregnancies complicated by gestational diabetes mellitus (39.7u/ml), intrahepatic cholestasis of pregnancy (64.3u/ml), or heart disease (54.0u/ml) (p<0.05 for all). |
| PubMedID- 23653531 | Patients having systemic hypertension, diabetes mellitus, history of ischemic heart disease, significant valvular heart disease, chronic obstructive pulmonary disease, hypo- or hyperthyroidism, renal failure or any associated systemic disease were excluded. |
| PubMedID- 22536293 | Our survey showed that ami patients who had a history of stroke and coronary heart disease, combined with hypertension, diabetes mellitus patients and many hospitalized history had a relatively higher mortality, considering related to the factors as combined with more disease, relatively complex and worse vascular condition. |
| PubMedID- 26457543 | Importance: there is a well-described association between maternal diabetes mellitus and risk of congenital heart disease (chd) in offspring. |
| PubMedID- 20821933 | Conclusion: the results have shown a low proportion of coronary heart disease patients, especially with diabetes mellitus and metabolic syndrome, who reached the recommended therapeutic targets for cardiometabolic risk profile parameters, in spite of widely used cardioprotective drugs, and therefore clearly demonstrated the compelling need for more effective lifestyle management in the secondary prevention of coronary heart disease. |
Page: 1